Clinical trial
A Study of the Safety and Efficacy of a New Treatment for Macular Edema…
NCT00168324 · Allergan, Industry · Completed
Key facts
| NCT number | NCT00168324 |
|---|---|
| Title | A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein Occlusion |
| Lead sponsor | Allergan, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Macular Edema, Retinal Vein Occlusion |
| Intervention type | Drug, Other |
| Interventions | 700 µg Dexamethasone, 350 µg Dexamethasone, Sham Injection |
| Enrollment | 599 |
| Start date | Oct 1, 2004 |
| Primary completion | Mar 1, 2008 |
| Completion | Oct 1, 2008 |
| First posted | Sep 15, 2005 |
| Last update posted | Apr 23, 2019 |
| Countries | Australia, Austria, Canada, Czechia, France, Germany, Israel, Mexico, Philippines, Portugal, South Africa, Taiwan and 1 more |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: